[4]
Wan, P.; Sun, J.G.; Hao, G.; Zhang, X.X.; Xiao, D.W.; Liu, Z.H. Determination of rhein in plasma, urine and feces by HPLC-fluorescence detection and its pharmacokinetics in healthy volunteers. J. China Pharm. Univ., 2013, 44, 73-76.
[12]
Proter, S.P.A. Anthraquinone derivatives for the treatment of arthritis, IT1098332B1985.
[13]
Friedmann, CA Anthraquinone derivatives for the treatment of arthritis, FR2508798B11986.
[14]
Dall’asta, L; Coppi, G; Scevola, M.E. Diacetylrhein potassium salt and its therapeutical use in the treatment of arthritis, EP0243968B11991.
[15]
Cong, X.D.; Zhang, Y.; Dai, D.Z.; Dai, Y.; Chen, G.X. Application of complexes of rhein or rhein compounds in preparation of medicine for treating osteoarthritis, CN1899275B2013.
[16]
Cong, X.D.; Zhang, Y.; Dai, D.Z.; Dai, Y.; Chen, G.X. Application of complexes of rhein or rhein compounds in preparation of medicine for treating diabetic nephropathy, CN1899277B2013.
[17]
Cong, X.D.; Zhang, Y.; Dai, D.Z.; Dai, Y.; Chen, G.X. Application of complexes of rhein or rhein compounds in preparation of medicine for recovery of gastrointestinal function and prevention of intestinal adhesion, CN1899276B2014.
[18]
Cong, X.D.; Dai, D.Z.; Zhang, Y.; Dai, Y. Application of complexes of rhein or rhein compounds and arginine in preparing medicine for treating diabetic vascular complications, CN103202829A2013.
[19]
Cong, X.D.; Dai, D.Z.; Zhang, Y.; Dai, Y. Application of complexes of rhein or rhein compound and arginine in preparing medicine for treating diabetic vascular complications, CN103169690A2013.
[20]
Liu, D.H.; Zhao, Z.Y. A Chinese medicle powder injection for treating arthritis and its preparation method, CN1712041A2005.
[21]
Charbit, S.; Schutze, F.; Provvedini, D.; Ficheux, H. Use of a rhein in a therapeutic treatment requiring a rise in the rate of heme oxygenase, US20060058392A12006.
[22]
Brown, C.O., III; Chen, Z.G.; Li, J.Y.; Lu, W.S. Diacerein or its analogs for inhibiting the expression of ASC, the expression of NLRP3 and/or the formation of NLRP3 inflammatory complexes, CN108349867A, 2018.
[23]
Pietrangelo, A; Travagli, V Esters of hyaluronic acid with rhein, process for their preparation and compositions comprising the same, EP1718679B12007.
[24]
Carlino, S.; Napoli, A.D. Dioxoanthracene sulphonate derivatives, EP2220036B12012.
[25]
Rosini, S; Mian, M. 4,5-dihydroxy- and 4,5,8-trihydroxy- 9,10-dihydro-9,10-dioxo-2-anthracenecarboxylic acid dicarbonates and urethans having therapeutical activities, US5362750A1994.
[26]
Rosini, S.; Mian, M. Acylamino-alkyliden-hydroxy-bisphosphonic acids esters and salts thereof, wherein the acyl group is derived from an acid having antiinflammatory activity, US5466682A1995.
[27]
Rosini, S.; Mian, M. Anthraquinone compounds useful to treat osteoarticular conditions, pharmaceutical compositions and method of treatment, US5451606A1995.
[28]
Rosini, S; Mian, M. Arylalkyl esters of 4,5-dihydroxy-9,10-dihydro-9,10-dioxo-2-anthracenecarboxylic acid having therapeutical activity, US5330981A, 1994.
[29]
Cifter, U.; Turkyilmaz, A. AKALIN N.P.; ZENGINER, S.; Mutlu, O. Combinations of diacerein and non-steroidal inflammation drugs, EP2797584B12015.
[30]
Benetti, D; Aloisi, R; Guainai, G; Rosini, S. Mono- and disulfosubstituted anthraquinones and their use for the treatment of bone matrix disorders, US5856358A1999.
[31]
Napoli, G.D. Rhein derivatives and new processes for producing rhein derivatives, US5864048A1999.
[32]
Quirk, S. Matrix metalloproteinase inhibitors, US6600057B22003.
[33]
Bannister, R.M.; Baxter, A.D.; Cooper, N.; Brew, J. 1,8-dihydroxyanthraquinone-6-carboxamide derivatives as modulators of IL-10 production for treatment of autoimmune or inflammatory conditions, GB2398779A2004.
[34]
Baxter, A.D.; Walmsley, A. Ester derivatives of rhein and their therapeutic use, US7728035B22010.
[35]
Li, J.C.; Huang, P.; Liu, Y.W. Rhein derivatives and their therapeutic use, CN102225913B2013.
[36]
Li, J.C.; Huang, P.; Niu, Q. Ether derivatives of rhein and their therapeutic use, CN102225896B2013.
[37]
Jiang, M.; Xu, X.; Qi, X.Y.; Yang, C.H.; Deng, L.F. A class of rhein compounds and their uses, CN105884645B2018.
[39]
Jiang, M.; Xu, X.; Deng, L.F.; Jiang, B.; Yang, C.H. Rhein thioamide compounds,their preparation and use, CN107298648B2019.
[42]
Li, L.Z.; Cui, Y.; Zhang, Y.L.; Cui, Y. Rhubarb anthraquinone derivatives, and their preparation and pharmaceutical compositions, CN100368426C2008.
[43]
Tang, L.; Wang, J.T.; Zhu, G.F. Bisphosphonate rhein ether derivatives with bone affinities and their preparation method, CN101735271A2010.
[44]
Ji, M.; Duan, Y.B.; Yu, J. Synthesis method and application of bone-targeted anti-inflammatory drugs, CN101475484B2012.
[46]
Xie, H.B.; Gu, S.H.; Lv, W.H.; Li, Q.Y.; Hu, H.F. Rhein derivatives and their application, CN104926754A2015.
[47]
Xie, H.B.; Gu, S.H.; Lv, W.H.; Li, Q.Y. A carboxylic ester derivative of rhein and its application, CN104945269A2015.
[48]
Chen, L.J.; Li, Y.; Wang, X.; Jia, D.C.; Cui, Q.G. Rhein ester derivatives and their preparation and application, CN106631808A2017.
[51]
Gallagher, P.T.; Owton, W.M.; Williams, A.C. Pharmaceutical compounds, US5792797A1998.
[52]
Yang, C.H.; Miu, Z.H.; Yue, Z.Z.; Liang, Y.K.; Feng, J.M.; Li, J.X; He, Q. Anthraquinone and thiazole compound, preparation method and application thereof, CN104250246B2017.
[53]
Wang, H.S.; Huang, R.Z.; Pan, Y.M.; Yao, G.Y.; Dai, W.L.; Ye, M.Y; Chen, Z.F Rhein aminophosphonate derivatives,and their synthesis method and application, CN103524555B2016.
[54]
Wang, H.S.; Huang, R.Z.; Pan, Y.M.; Yao, G.Y.; Dai, W.L.; Ye, M.Y; Chen, Z.F. Diacerein aminophosphonate derivatives,and their synthesis method and application, CN103524556B2016.
[55]
He, L.Q.; Huang, J.K. Rhein aminol ester derivatives,their preparation and medical use, CN103709052B2016.
[56]
Huang, J.K.; He, L.Q.; Huang, P.; Bai, Z.W.; Zhang, W.W. Synthesis of rhein aminol ester derivatives and their anti-osteosarcoma cell activity. Acta Pharm., 2018, 53, 249-255.
[57]
Lin, Y.J.; Zhen, Y.S.; Liu, X.J.; Wu, S.Y.; Xu, X.D. Preparation process of lysine rhein and its application in tumor therapy, CN101255121B2012.
[58]
Lin, Y.J. Preparation of lysine rhein and its anti-tumor mechanism. Ph.D; Peking Union Medical College, 2008.
[59]
Xu, W.Q.; Li, J.Y.; Zhu, Z.H.; Li, G.Q.; Shen, X.; Zhang, Y.J. Rhein derivatives,their synthesis method and use, CN103864642B2016.
[60]
Xie, J.W.; Zhou, C.J.; Dai, B.; Zhang, J.; Liu, P. A rhein compound and its preparation and application, CN104557603A2015.
[61]
Chen, H.S. Platinum salts of organic acids, preparation thereof and application in preparation of anticancer drugs, CN101289467A2008.
[62]
Ou, B.N.; Li, L.Q. Ester derivatives of rhein polyol and their use for preparing antitumor medicine, CN104529782A2015.
[63]
Liu, H.K.; Kong, Y.Q.; Qian, Y.; Su, Z.; Li, J.; Wu, J. Organic compounds modified by rhein-specific group, and their aryl metal complex, preparation method and application, CN108530343A2018.
[66]
Wang, B.H.; Dai, C.F.; Draganov, A.; Yang, X.C.; Sun, G.J.; Yang, C.H.; Chen, W.X.; Ni, N.T.; Zhou, M.X.; Gu, L.B. Anthraquinone analogs and methods of making and using thereof US20150203442A1, 2015.
[67]
Hou, H.X.; Tian, W.; Li, D.R. Preparation and application of an anthraquinone compound for inducing para-apoptosis of liver cancer cells, CN108586278A2018.
[71]
Li, L.S. Use of rhein or rhein salts in the preparation of medicine for treating diabetic nephropathy, CN1086289C2002.
[72]
Zhang, Y. Application of rhein or its salt in preparing medicine for treating chronic nephritis or chronic renal failure, CN101301284B2010.
[73]
Wang, C.P.; Sun, W.X.; Fang, Z.; Lu, C.L.; Zhu, Z.H.; Mao, L.Z.; Zhang, H.Y.; Zhu, M.H; Zhang, H.Y.; Zhu, M.H. Rhein and berberine ion pair compound, its preparation method and application, CN103319479B2015.
[74]
Gu, S.H.; Cao, H.; Sun, W.X. A rhein derivative and its preparation and use, CN102060809B2015.
[75]
Li, X.G.; Zhu, X.K.; Ye, X.L. 3-alkoxy-6-carboxyl rhein or pharmaceutically acceptable salt, and their preparation method and application, CN101613271B2013.
[76]
Zhang, F.Y.; Chen, Q.Y. Water-soluble choline salt of rhein and its derivatives, their preparation and application in medicine, CN103965062A2014.
[80]
López-Ibarra, D.M.T.; Cantín, N.M.I; Gaza, E.V.; Lao, I.S.; Cruz, S.V. Beta-amyloid-directed multitarget compounds for the treatment of alzheimer’s disease, US9238626B22016.
[81]
Liu, J.B. Esters of anthraquinone acid and kojic acid, and their application as tyrosinase inhibitors, CN108546259A2018.
[82]
Liu, J.B. Application of rhein and its vitamin C ester derivatives as tyrosinase inhibitors, CN108586400A2018.
[84]
Hua, X.; Liu, S.G.; Zhang, W.J. A medicine for preventing and treating haemophilus parasuis and its application, CN106955280A2017.
[85]
Yang, J.Q.; Zhao, S.X.; An, J.L.; Deng, L.; Lei, Y.Y. Rhein ester derivatives and their preparation method and application, CN109053798A2018.
[86]
Qin, Y.; Sheng, X.Y. Application of rhein in the prevention and treatment of fatty liver, CN101327204B2010.
[87]
Liu, L.P. Conjugated compounds of ursodeoxycholic acid with berberine or L-carnitine and their composition and method, CN108137575A2018.
[88]
Ju, X.W.; Hou, X.H.; Fan, G.P.; Bai, S.F.; Zhang, J.Z.; An, Q.; Chen, H. Synthesis and bone affinity of rhein-N-β-hydroxyethyl tegafurate. J. Chin. People’s Armed Police Acad., 2008, 375-377.
[89]
Wang, Z.M.; Chen, H.; Cao, B.; Wang, Y.; Mou, H.J. Study on the mechanism of action of rhodophyllotoxin ester on human osteosarcoma cells. Chin. Herb. Med., 2008, 67-71.
[95]
Xiang, H. Research on the structure and pharmacological action of rhein metal complex. Master; Chengdu University of Traditional Chinese Medicine, 2014.
[96]
Wang, X.D.; Li, L.; Han, Y.P. Synthesis and antibacterial activity of rhein derivatives. Forest Prod. Chem. Indust., 2018, 38, 105-111.
Download PDF Flyer